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Regenerative failure remains a significant barrier for functional recovery after central
nervous system (CNS) injury. As such, understanding the physiological processes that
regulate axon regeneration is a central focus of regenerative medicine. Studying the
gene transcription responses to axon injury of regeneration competent neurons, such
as those of the peripheral nervous system (PNS), has provided insight into the genes
associated with regeneration. Though several individual “regeneration-associated genes”
(RAGs) have been identified from these studies, the response to injury likely regulates the
expression of functionally coordinated and complementary gene groups. For instance,
successful regeneration would require the induction of genes that drive the intrinsic
growth capacity of neurons, while simultaneously downregulating the genes that convey
environmental inhibitory cues. Thus, this view emphasizes the transcriptional regulation
of gene “programs” that contribute to the overall goal of axonal regeneration. Here, we
review the known RAGs, focusing on how their transcriptional regulation can reveal the
underlying gene programs that drive a regenerative phenotype. Finally, we will discuss
paradigms under which we can determine whether these genes are injury-associated,
or indeed necessary for regeneration.
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It likely comes as no surprise the striking dichotomy that exists between peripheral nervous
system (PNS) and central nervous system (CNS) neurons following injury. While PNS
neurons show robust regenerative capacity, CNS neurons exhibit negligible capacity. This
difference has been known and intensively studied since the time of Ramón y Cajal, and in
those years many reasons have been postulated for this fundamental difference (Ramón y
Cajal, 1914). What then have we learned from nearly 100 years and hundreds of studies
trying to unravel this mystery? Deservingly, the gene transcription response to axon injury
has drawn considerable interest; however, its increasingly appreciated complexity poses a
formidable challenge from a therapeutic perspective. Given this potential hurdle, ongoing
work has given hope that if the appropriate manipulations of neuronal physiology are
enacted, both the central and PNS could be efficiently repaired.
What Evidence Pointed to the Importance of Regeneration
Associated Genes (RAGs)?
Regeneration of damaged axons is dependent on the neuron-intrinsic transcription
of regeneration-associated genes (RAGs). Axotomy of PNS neurons induces broad
and coordinated gene transcription, a response that is lacking following CNS injury
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(Schreyer and Skene, 1993; Mason et al., 2002; Starkey et al.,
2009; Ylera et al., 2009; Geeven et al., 2011). These differences
in the ability to induce RAG expression, along with extracellular
environmental factors, underlie the disparate ability of PNS and
CNS axons to regenerate (Filbin, 2003).
Early observations that peripheral axon injury induced
a ‘‘cell body’’ response that included increased neuronal
mRNA and protein synthesis indicated an active process
by which peripheral neurons prepared to regenerate axons
(Lieberman, 1971; Grafstein, 1975). Along with findings that
specific axonal proteins were upregulated following injury
(i.e., GAP43), the idea that the expression of growth-related
proteins promoted the regeneration of axons began to take
hold (Skene and Willard, 1981; Skene, 1989; Tetzlaff et al.,
1991). As a result of these early observations, the hypothesis
formed that injury-induced gene transcription was required for
axon regeneration, and importantly, raised the possibility that
the expression of RAGs may confer regenerative capacity to
CNS neurons.
This brought to question whether the primary driver of
regenerative failure in the CNS was due to the inhibitory
environment or the failure to appropriately upregulate RAGs. If
the latter, it suggested that a reasonable course of action to confer
regeneration capacity to the CNS was to identify and manipulate
the RAGs responsible for the PNS response.
What Constitutes a RAG?
With the early evidence suggesting that the regenerative
transcriptional response could be used to improve regeneration,
both under permissive and non-permissive conditions,
considerable effort has been directed at identifying the genes
that are upregulated following injury and designing methods
to modulate their expression to enhance regeneration in CNS
neurons.
Several seminal observations supported the existence of
neuron-intrinsic factors capable of promoting CNS regeneration.
Though typically incapable of spontaneous regeneration, CNS
neurons will regenerate damaged axons when provided a
permissive environment. Indeed, some damaged spinal cord
axons grow into transplanted peripheral nerve segments in the
rat spinal cord, indicating that these CNS neurons retained
the intrinsic capacity to regenerate given a permissive (or
growth-stimulating) environment (David and Aguayo, 1981).
Interestingly, though not all types of CNS neurons exhibit this
behavior, those that could regenerate upregulate RAG expression
in the presence of the graft (Anderson et al., 1998; Mason et al.,
2002; Murray et al., 2011).
Manipulations that increase RAG expression in CNS can also
promote regeneration of ‘‘resistant’’ axons into these nerve grafts.
For instance, treatment with BDNF of rubrospinal neurons
induces RAG expression and growth into peripheral nerve grafts,
while upregulating cyclic adenosine monophosphate (cAMP)
levels can increase RAG expression and allow modest CNS
axon regeneration in in vivo CNS injury models (Kobayashi
et al., 1997; Ye and Houle, 1997; Neumann et al., 2002; Qiu
et al., 2002; Li et al., 2003; Storer et al., 2003; Jin et al.,
2009). Indeed, cAMP is one of the few manipulations that
has repeatedly been shown to drive axon regeneration in a
variety of CNS injury models performed by numerous research
groups.
Dorsal root ganglia (DRG) neurons have provided an
important in vivo platform to test whether RAG induction allows
regeneration of CNS axons. These sensory neurons possess
pseudounipolar axons that extend in the periphery and into
the spinal cord; a subset of these axons ascend the dorsal
column of the spinal cord (Bradbury et al., 2000). Peripheral
nerve injury (transection or crush) induces the expression of
RAGs, whereas injury to the central projecting branch does
not (Schreyer and Skene, 1993; Smith and Skene, 1997; Mason
et al., 2002; Hanz et al., 2003; Seijffers et al., 2006; Ylera et al.,
2009; Geeven et al., 2011). Intriguingly, a peripheral conditioning
lesion enhances regeneration of proximally reinjured peripheral
axons, and allows regeneration of a subsequently injured central
branch (McQuarrie and Grafstein, 1973; McQuarrie et al., 1977;
Oblinger and Lasek, 1984; Neumann and Woolf, 1999). These
observations have led to substantial research efforts aimed
at understanding this mechanism. This conditioning lesion
effect was shown to be transcription dependent, indicating
that the physiological induction of RAG transcription confers
regenerative capacity to an otherwise regeneration-deficient axon
(Smith and Skene, 1997). Together, these observations indicate
that the expression of genes induced by peripheral axon injury
are necessary for spontaneous regeneration and the forced
expression of these (by peripheral injury) can be sufficient to
drive regeneration of CNS axons.
Though many candidate RAGs have been identified, genome-
wide profiling studies have provided a comprehensive view of the
transcriptional changes that result from peripheral axon injury
(Zigmond et al., 1998; Costigan et al., 2002; Xiao et al., 2002;
Schmitt et al., 2003; Tanabe et al., 2003; Küry et al., 2004; Di
Giovanni et al., 2005; Bosse et al., 2006; Stam et al., 2007; Szpara
et al., 2007;Moore et al., 2009; Zou et al., 2009;Michaelevski et al.,
2010; Geeven et al., 2011; Ma et al., 2011; Blesch et al., 2012).
From these, it is apparent that the expression levels of thousands
of genes are changed by injury. Elucidating the identity and
function of intrinsic contributors to regeneration has been
aided by numerous studies performed in lower vertebrates
and invertebrates, which offer advantages of forward genetic
screens and in vivo imaging, and complement those studies
performed in mammals. They offer insights into how injury-
induced gene expression both recapitulates and differs from
pathways involved during development. For example, screening
654 conserved genes in an axotomy model of mechanosensory
neurons in C. elegans identified clusters of genes that promote
or repress axon growth. Many of these are components of
pathways critical for neuronal plasticity of both development
and regeneration; however, some clusters are only required for
regeneration (Chen et al., 2011). This highlights how the repair
process utilizes plasticity mechanisms important for neuronal
development, but also has members unique to the repair process.
As with development and many other biological processes, these
genes function in regulatory networks and are interconnected by
their interactions with other genes (Figure 1). Genes in a network
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FIGURE 1 | Regeneration-associated gene networks. Axonal injury
activates many signal transduction pathways that can lead to gene
transcription. The upregulation of cAMP levels after injury is important for RAG
expression, serving to activate CREB, AP1, and possibly other transcription
factors in parallel. These transcription factors can serve as hub proteins (in
yellow circles) to control the transcription of terminal RAGs (in gray circles) that
may serve related physiological functions. Some hub proteins, such as CREB,
drive the transcription of other hub proteins. In this case, AP1 subunits and
ATF3 are direct CREB target genes. As such, CREB is a highly connected node
of the RAG transcription network and serves to coordinate the transcription of
many terminal RAGs through their proximal hub proteins. These highly
connected nodes are attractive therapeutic targets that can recapitulate more of
the RAG response and can be targeted by viral-mediated gene delivery
(i.e., constitutive-active CREB, virus cartoon). Additionally, injury-induced signals
may also work locally and interact with the protein products of the transcribed
RAGs to augment axon growth. Thus, strategies that increase/induce RAG
expression along with activation of injury signals (i.e., cAMP, syringe and pill
cartoon) may show synergy in promoting axon regeneration.
can be ‘‘connected’’ in various ways, including by experimental
evidence for physical interaction of the gene products (proteins),
common gene function, or predicted regulation by signaling
pathways or transcription factors. Because the gene network
induced by injury is large and may contain redundant and/or
complimentary genes, manipulating singe (or small subsets)
of terminal genes is unlikely to recapitulate the effect of the
entire regenerative ‘‘program.’’ Equally unlikely is our ability to
experimentally recapitulate the entirety of the injury response.
Genes that have many connections act as ‘‘hubs’’ that
coordinate the expression or activity of the connected genes
(Batada et al., 2006; Van Kesteren et al., 2011; Song and
Singh, 2013). Transcription factors serve as hubs in gene
regulatory networks, and as such, are attractive targets for
the manipulation of many genes that may sub serve common
functions (Figure 1). Transcription-associated networks can be
built by connecting genes based on the presence of promoter
transcription factor binding sites in silico (Michaelevski et al.,
2010; Geeven et al., 2011). Along with profiling of the
injury-induced phosphoproteome to determine the associated
signaling pathways activated, one study has distilled the
RAG network to ∼40 transcription factors downstream of
multiple parallel signaling pathways (Michaelevski et al., 2010).
Other independently identified transcription factors include
ATF3, c-Jun, C/EBPβ, CREB, KLF family members, p53,
SMAD1, SOX11, and STAT3 among others (Jenkins and
Hunt, 1991; Herdegen et al., 1997; Schwaiger et al., 2000;
Tsujino et al., 2000; Schweizer et al., 2002; Gao et al.,
2004; Nadeau et al., 2005; Jankowski et al., 2006; Okuyama
et al., 2007; Moore et al., 2009; Zou et al., 2009). It should
be noted that the expression levels of some transcription
factors might not be upregulated by injury (i.e., CREB
and p53); however, their activity is induced and contribute
to the overall RAG response (Gao et al., 2004; Tedeschi
et al., 2009). While this number of pathways/transcription
factors remains daunting, it brings to question whether the
entire injury response is necessary to facilitate regeneration,
and whether all injury-induced genes are necessarily RAGs
(Table 1).
Individually identified (not via microarray) non-transcription
factor ‘‘terminal’’ RAGs span many functional categories,
including genes that encode adhesion/guidance molecules (i.e.,
integrin subunits, CD44; Kloss et al., 1999; Jones et al., 2000),
neuropeptides (i.e., VIP, Gal, CGRP, NPY, PACAP, etc.; Mohney
et al., 1994; Holmes et al., 2000; Suarez et al., 2006; Sachs et al.,
2007; Armstrong et al., 2008; Toth et al., 2009), structural and
cytoskeletal-associated proteins (i.e., GAP43, CAP23, SCG10,
CRMP2, Sprr1a; Skene and Willard, 1981; Bomze et al., 2001;
Bonilla et al., 2002; Iwata et al., 2002; Mason et al., 2002;
Suzuki et al., 2003), and metabolic enzymes (i.e., arginase 1;
Cai et al., 2002). The contribution of specific RAGs to axon
regeneration/growth (either in the PNS or CNS neurons) has
been assessed both in vitro and in vivo by evaluating their
sufficiency or necessity for the regenerative response. Necessity
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TABLE 1 | Regeneration-associated transcription: RAGs and genetic manipulations that alter axon regeneration after injury in vivo.
Gene (s) Regeneration phenotype after injury Reference
Terminal RAGs
α7 integrin Knockout delayed facial nerve regeneration Werner et al. (2000)
BDNF Conditional knockout decreased sciatic nerve axon growth into peripheral nerve graft; adenoviral
overexpression in sensorimotor cortex neurons increased CST axon sprouting/midline crossing
Zhou and Shine (2003)
and English et al. (2013)
β2-microglobin Knockout decreased sciatic nerve motor axon regeneration Oliveira et al. (2004)
Cdc42 Delivery of constitutive-active protein by hydrogel increased CST tract axon growth through spinal
cord lesion
Jain et al. (2011)
CGRP Local siRNA against CGRP at site of axon injury reduced regeneration of sciatic nerve Toth et al. (2009)
CRMP2 Adenoviral overexpression increased hypoglossal motor axon regeneration Suzuki et al. (2003)
Galanin Knockout decreased sciatic nerve regeneration Holmes et al. (2000)
Galectin-1 Knockout delayed functional recovery of whisker movement after facial nerve crush; allograft treated
with recombinant-oxidized galecitin-1 increased axon regeneration into sciatic nerve
Fukaya et al. (2003) and
McGraw et al. (2004)
GAP43 + CAP23 Double transgenic overexpression increased central sensory axon regeneration into a peripheral nerve
graft in the spinal cord
Bomze et al. (2001)
GDNF Transplanted fibroblasts expressing GDNF at spinal cord transection sites increased spinal cord axon
regeneration
Blesch and Tuszynski (2003)
Hsp27 Transgenic overexpression increased sciatic nerve motor and sensory axon growth rate and
functional recovery
Ma et al. (2011)
IL6 Knockout delayed sciatic nerve regeneration; intrathecal injection of IL6 increased dorsal column
sensory axon regeneration
Zhong et al. (1999) and
Cao et al. (2006)
p21cip1/WAF1 Knockout delayed sciatic nerve motor axon regeneration and functional recovery Tomita et al. (2006)
PACAP Knockout decreased facial nerve regeneration; PACAP delivery by hydrogel increased regenerating
axons in contusion model of SCI
Armstrong et al. (2008)
and Tsuchida et al. (2014)
Rac1 Delivery of constitutive-active protein by hydrogel increased CST axon growth through spinal cord
lesion
Jain et al. (2011)
Regeneration-associated
transcription factors
ATF3 Overexpression increased sciatic nerve regeneration Seijffers et al. (2007)
C/EBPdelta Knockout delayed sciatic nerve regeneration Lopez De Heredia and
Magoulas (2013)
c-Jun Knockout reduced facial nerve reinnervation and delayed functional recovery Raivich et al. (2004)
CREB Adenovirus overexpression of constitutive-active CREB in DRG neurons increased dorsal column
sensory axon regeneration
Gao et al. (2004)
KLF7 AAV overexpression of constitutive-active KLF7 of sensorimotor cortex neurons increased CST tract
axon regeneration
Blackmore et al. (2012)
p53 Knockout decreased number of regenerating facial nerve axons Tedeschi et al. (2009)
SMAD1 Increasing SMAD1 activity with BMP4 in DRG neurons increased dorsal column axon regeneration Parikh et al. (2011)
SnoN AAV overexpression of degradation-resistant SnoN in DRG neurons increased dorsal column axon
regeneration
Do et al. (2013)
SOX11 Knockdown with membrane-permeable siRNA decreased sciatic nerve regeneration; HSV
overexpression accelerated saphenous nerve regeneration
Jankowski et al. (2009)
and Jing et al. (2012)
STAT3 Knockout in DRG neurons decreased the initiation of regenerating peripheral axons while AAV
overexpression increases terminal sprouting of dorsal column axons; AAV overexpression in motor
cortex increased CST axon sprouting
Bareyre et al. (2011) and
Lang et al. (2013)
AAV, adeno-associated virus; CST, cortical spinal tract; HSV, herpes simplex virus; SCI, spinal cord injury, siRNA, small-interfering RNA.
is addressed by either pharmacological inhibition or genetic
attenuation/deletion of the candidate RAG. These studies often
show that knockdown of individual downstream RAGs results
in small decreases, or delays, in peripheral regeneration. By
contrast, deletion of possible hub proteins (transcription factors
or kinases) leads to more dramatic effects in vivo. For example,
genetic knockout of c-Jun, the first identified transcription factor
RAG, reduced re-innervation of peripheral targets by 4-fold
after facial nerve axotomy and was associated with decreased
induction of its downstream target RAGs α7 integrin, CD44, and
galanin (Herdegen et al., 1991; Jenkins and Hunt, 1991; Raivich
et al., 2004). By contrast, deletion of α7 integrin or galanin only
delayed target re-innervation and functional recovery (Holmes
et al., 2000; Werner et al., 2000). This dichotomy also holds true
for the above-mentioned terminal RAGs and hub transcription
factors. Taken together, these studies suggest that the modulation
of any single downstream RAG is unlikely to have robust effects
on overall regeneration.
Similarly, sufficiency experiments have yielded mixed effects
as the overexpression of terminal RAGs or transcription factors
can recapitulate some aspects of peripheral nerve injury, but none
capture the phenotypic entirety of the regenerative ‘‘program.’’
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For instance, though there was much interest in GAP43 as a
RAG, its overexpression failed to promote regeneration in many
CNS injury models, though it induced significant sprouting
(Buffo et al., 1997; Harding et al., 1999; Mason et al., 2000).
Instead, the co-expression of both GAP43 and CAP23, two
related growth cone proteins, was required to drive regeneration
into a peripheral nerve graft in the spinal cord (Bomze et al.,
2001). While the overexpression of some hub transcription
factors facilitated in vivo regeneration, these effects were also
mixed. One example was ATF3, whose overexpression afforded
only increased PNS (but not CNS) axon regeneration in vivo.
Further, ATF3 overexpression did not allow axon growth on
inhibitory substrates in vitro, suggesting that ATF3 increases the
intrinsic growth of axons, but does not alter its response to the
inhibitory environment of the CNS (Seijffers et al., 2007). By
contrast, STAT3 overexpression seems to allow the initiation of
CNS axon growth, but does not sustain its elongation (Bareyre
et al., 2011). Taken together, the disparate effects of targeting
transcription factors also suggests that each may play specific
roles in the regeneration process, and that several hubs may
need to be manipulated for a sufficient response (Figure 1).
Table 1 lists manipulations of terminal RAGs and regeneration-
associated transcription factors that have been shown to impact
axon growth in vivo.
Interestingly, some injury-induced genes may actually oppose
axon growth. For instance, though both SOCS3, which
suppresses cytokine signaling, and NFIL3, a transcription
factor, are strongly induced by peripheral injury, their deletion
or attenuation promotes axon growth (Miao et al., 2006;
MacGillavry et al., 2009; Smith et al., 2009). Overexpression of
SOCS3 further decreased axon growth, supporting that not all
injury-induced genes are necessarily RAGs, and that attenuating
negative regulators of axon growth may be beneficial (Miao
et al., 2006). This further underscores the notion that not every
component of the injury response is contributing to regeneration.
Sufficiency for Therapeutics?
As the changes in gene transcription following axon injury are
broad, how do we assess whether they are truly regeneration-
associated? As discussed, though many necessity studies show
the contribution of candidate injury-induced RAGs to the
regenerative response, the sufficiency of their expression in
driving regeneration is typically modest. Therapeutic approaches
must leverage the sufficiency of genes and transcriptional
pathways, organized into larger hubs or programs, to drive axon
growth and regeneration. For this purpose, genes and pathways
that may not be normally recruited by injury could also be
considered.
Given that many of the pro-regenerative pathways identified
are involved in the neuronal plasticity during development,
one major effort has been to reconstitute certain aspects
of a ‘‘younger’’ developmental state in which CNS neurons
are axon growth competent. These studies sought specific
genes, transcription factors, or signaling pathway components
that were changed between developmental epochs where CNS
neurons lose their regenerative capacity. For example, the
activation of Raf-MEK-ERK pathway that is a dominant
driver of developmental axon growth downstream of growth
factor signaling can also drive robust CNS axon growth in
adult neurons (Hollis et al., 2009; O’Donovan et al., 2014).
Other developmentally-regulated targets that, when modulated,
increase CNS axon growth include transcription factors (KLF
family, SnoN; Moore et al., 2009; Blackmore et al., 2012; Do
et al., 2013), transcriptional/epigenetic regulators (Set-B and
P300; Tedeschi et al., 2009; Trakhtenberg et al., 2014), and others
(let-7 microRNA; Zou et al., 2013). It should be noted that
some negative regulators of axon regeneration, such as KLF4, are
upregulated during development in CNS neurons; attenuation of
these genes, as with injury-induced inhibitors of axon growth,
may be significant adjuncts to driving growth-associated targets
(Moore et al., 2009).
Another fruitful strategy has been to increase the ‘‘metabolic
growth state’’ of CNS neurons, focusing on upregulating anabolic
processes such as protein translation through mTOR activation
[i.e., Phosphatase and tensin homolog (PTEN) deletion or Rheb
activation] or transcriptional regulation of anabolic processes
(i.e., c-myc overexpression), all of which increase CNS axon
growth after injury (Park et al., 2008; Liu et al., 2010; Kim
et al., 2011; Belin et al., 2015). While these processes may decline
with development in CNS neurons, augmenting these pathways
also counteracts some injury-induced deficits such as mTOR
and c-myc activity reduction, and is thought to provide the
metabolic and energetic substrates required for axon growth
(Park et al., 2008; Belin et al., 2015). These studies have also led
to combinatorial approaches that pair increased metabolic state
(PTEN deletion) with other manipulations that increase axon
growth. Indeed, the co-deletion of PTEN and SOCS3, co-deletion
of PTEN and SOCS3 plus c-myc overexpression, and deletion
of PTEN plus BRaf activation have yielded highly robust long
distance axon growth of injured optic nerves, with evidence for
synergistic interaction of each manipulation (Sun et al., 2011;
O’Donovan et al., 2014; Belin et al., 2015).
Though not necessarily induced by peripheral axon injury,
the action of epigenetic modifiers has gained significant interest
in facilitating RAG transcription. This is especially true given
the difficulty in directly upregulating gene expression in vivo,
which likely limits the therapeutic potential of these types of
approaches. Epigenetic modification of DNA or DNA/protein
complexes of chromatin can dictate the transcriptional activity
of specific regions of DNA. The most studied of these in
regeneration is the acetylation of histone lysine residues.
Histones are aceytylated by histone acetyltransferases (HATs),
which ‘‘opens’’ the chromatin to allow access to the associated
genes for transcription. By contrast, histones are deacetylated by
histone deacetylases (HDACs), which ‘‘closes’’ the chromatin and
is typically repressive (Kouzarides, 2007). In this way,modulating
histone acetylation can control the expression of many genes.
Interestingly, peripheral axon injury, which drives regenerative
gene transcription, increases acetylation of histones at the
promoters of specific genes (some of which are RAGs), whereas
this acetylation is not evident after central axon injury (Finelli
et al., 2013; Puttagunta et al., 2014). In peripheral neurons, this
is the ‘‘routine’’ injury response and is mediated by induced
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PCAF activity, a HAT protein (Puttagunta et al., 2014). This
injury-induced increase in acetylation is associated with nuclear
export of HDAC5, which may serve to decrease the activity of
other HDAC isoforms (Cho et al., 2013). As such, augmenting
histone acetylation may foster the transcription of relevant
RAGs in CNS neurons. Indeed, overexpressing the HATs PCAF
and p300 leads to histone acetylation at the promoters of
specific genes and increased optic nerve and spinal cord axon
regeneration following injury (Tedeschi et al., 2009; Puttagunta
et al., 2014). Moreover, pharmacological inhibition of HDAC1
can also increase acetylation, drive RAG expression, and allows
central axon regeneration (Finelli et al., 2013). Interestingly,
some of the gene changes induced by these epigenetic modifiers
are discordant with the standard peripheral injury response,
indicating that some induced RAGs may be peripheral to the
regenerative response (Finelli et al., 2013; Puttagunta et al.,
2014). Both HATs and HDACs can affect the acetylation state
of non-histone proteins both in the nucleus and cytosol of
neurons. These modifications also play important roles in both
transcriptional (i.e., p53 regulation) and non-transcriptional (i.e.,
microtubule dynamics) aspects of axon growth (Rivieccio et al.,
2009; Tedeschi et al., 2009; Cho and Cavalli, 2012). While
targeting protein acetylation with small molecules is promising,
systemic administration of these drugs may be problematic
as acetylation/deacetylation is important for general cellular
physiology (Kouzarides, 2007). As such, there remains the need
for isoform-specific modulators and more tissue/cell selective
modes of drug delivery.
The reduced neuron-intrinsic injury-induced RAG response
is an important reason for the failure of CNS regeneration.
An interesting point to consider is why CNS neurons fail to
upregulate these RAGs in response to injury. What inhibitory
mechanisms prevent this response, and can we use this
information to inform approaches to enhance repair? As we have
discussed, the RAG program is regulated by transcription factors
and epigenetic modifications. In addition to these regulatory
mechanisms, post-transcriptional regulation of gene expression
likely plays a critical role in regulating this program as well.
The discovery of micro RNAs (miRNAs) and their role in
RNA interference have added greatly to our understanding
of regulation of gene expression. Based on bioinformatic
predictions, miRNAs likely regulate >30% of all mammalian
protein coding genes (Filipowicz et al., 2008). This mechanism
appears to be important in axonal regeneration, since deletion
of dicer has been shown to impair nerve regeneration in a
mouse model of peripheral nerve injury (Wu et al., 2012).
In addition, miRNA microarrays have identified a group of
miRNAs that are expressed following injury in regenerating
sciatic nerves (Strickland et al., 2011). Following spinal cord
injury, more than 50 miRNAs show significant changes in
expression levels. Among these is miR-145, which inhibits
neurite outgrowth in vitro by targeting robo2 and srGAP2
(Zhang et al., 2011). In addition, both miR-133 and miR-
124 are downregulated following CNS injury. Both of these
are implicated in axonal regeneration, with miR-133 known
to target the growth inhibitor RhoA. Dysregulation of target
mRNA expression by alteration of miRNA levels may result
in a failure to sustain the regenerative response, leading to
failed CNS regeneration. The possibility of using miRNAs as
therapeutic targets, either by anti-miRNA molecules or miRNA
mimetics, offers a highly attractive ability to modulate RAG gene
expression.
Intrinsic Signals: cAMP and Conditioning
Lesion Effect—What is the Role of
cAMP-Mediated Transcription?
The induction of RAG expression by axon injury indicates an
active process by which injured neurons sense axonal damage
to activate an adaptive response. This can be achieved by the
disruption of the retrograde flow of target-derived trophic signals
(i.e., loss of NGF; Raivich et al., 1991; Gold et al., 1993), activation
of existing or newly synthesized local (axonal) factors that are
retrogradely transported (i.e., DLK, JNK, STAT3, CREB; Hanz
et al., 2003; Cavalli et al., 2005; Cox et al., 2008; Ben-Yaakov et al.,
2012; Shin et al., 2012), and depolarization of the axon due to
the disruption of the plasma membrane (i.e., Ca2+ influx leading
to cAMP elevation; Ghosh-Roy et al., 2010; Cho et al., 2013).
Ultimately, the arrival of these signals to the cell body drives
the transcriptional changes that initiate regenerative response,
including the activation of transcription factors.
Interested in the molecular determinants underlying the
developmental loss of regenerative capacity, the Filbin lab
discovered a direct correlation between neuronal cAMP levels
and the ability of neurons to regenerate. For instance,
developmentally ‘‘younger’’ CNS neurons (i.e., early embryonic)
contained high levels of cAMP and retained the ability to
regenerate and overcome extrinsic axon growth inhibitors. This
is in contrast to mature neurons (i.e., adult), which are incapable
of regeneration and have markedly lower cAMP. In these studies,
the regenerative competence of embryonic neurons in vivo was
attenuated by pharmacological inhibition of PKA, an effector of
cAMP signaling, indicating the importance of cAMP in axonal
regeneration (Cai et al., 2001).
The importance of cAMP for driving axonal regeneration
is not restricted to CNS neurons. Using the peripheral
conditioning lesion model, the Filbin group showed that
peripheral axon injury induced cAMP levels in the soma
of peripheral neurons and that the in vitro effect of the
conditioning lesion are indeed dependent on PKA (Qiu et al.,
2002). Importantly, intraganglionic injection of db-cAMP, a
cell membrane permeable cAMP analog, could recapitulate the
conditioning lesion effect for neurons in both in vitro assays
and in vivo models of dorsal column injury (Neumann et al.,
2002; Qiu et al., 2002). Of note, the in vivo injection of db-cAMP
allowed DRG neurons to overcome myelin-associated inhibitors
in vitro in a biphasic manner. Acutely this effect was PKA-
dependent (after 1 day); however, this was PKA-independent if
the neurons were harvested 6 days after injection. These results
indicated that the transient elevation of cAMP set forth longer-
lived changes in neuronal function, which persist past the point
of elevated cAMP levels. These findings were seminal as they
identified a relevant, injury-induced secondmessenger that could
initiate the regenerative process (Qiu et al., 2002).
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How then does cAMP exert its benefit on axon regeneration?
In mammalian cells, cAMP is generated from ATP by a
family of either plasma membrane-bound or soluble adenylate
cyclase (AC) enzymes. Membrane-bound ACs are regulated
by the canonical heterotrimeric G-proteins, whereas soluble
isoforms are activated by bicarbonate. Both soluble- and some
isoforms of membrane-bound AC are also activated/regulated
by Ca2+ (Kamenetsky et al., 2006). Axonal damage causes the
depolarization of the neuron, and initiates a back-propagating
Ca2+ transient (Ghosh-Roy et al., 2010; Cho et al., 2013);
the generation of cAMP likely results from this elevation of
intracellular Ca2+. Indeed, electrical stimulation of the peripheral
nerves is sufficient to increase neuronal cAMP levels in the
cell body and can mimic some of the physiological effects of
the conditioning lesion (Udina et al., 2008). Recent reports
suggest a prominent role for soluble AC for axon growth,
as attenuating soluble AC activity, either pharmacologically
or genetically, decreases PKA-dependent basal axon growth
in RGCs, and prevents neurotrophin-mediated priming for
axon growth on myelin-associated inhibitory substrates in
vitro. Moreover, this inhibition of membrane-bound AC did
not recapitulate these effects, indicating that soluble AC was
the source of cAMP (Martinez et al., 2014; Stiles et al.,
2014).
The above studies serve to link the injury event to elevated
cAMP levels via a Ca2+-dependent regulation of AC activity.
cAMP likely exerts its effects locally, affecting nearby target
proteins. As such cAMP can function in both the axon and
cell body compartments of neurons to regulate axon growth. In
the axon/growth cone, cAMP regulates axonal guidance through
the PKA-mediated inactivation of RhoA signaling and by the
phosphorylation of other targets, which allows the cytoskeletal
rearrangement that supports growth cone motility (Song et al.,
1997; Ming et al., 2001; Kao et al., 2002; Murray et al., 2009;
Cheng et al., 2011; Nicol et al., 2011; Forbes et al., 2012).
Additionally, cAMP can also signal through EPAC to mediate
axon guidance (Murray et al., 2009). In the cell body, cAMP
may facilitate axon regeneration by inducing RAG transcription.
In this way, cAMP-activated PKA can directly activate CREB-
mediated gene transcription, or drive other signaling cascades
that can lead to gene transcription changes (Lonze and Ginty,
2002; Gao et al., 2004; Blesch et al., 2012; Ma et al., 2014).
Indeed, CREB has been linked to RAG transcription induced
by the conditioning lesion, and the expression of a constitutive-
active CREB protein can promote the regeneration of dorsal
column sensory axons in vivo (Gao et al., 2004). Both cAMP and
CREB are also necessary for synaptic plasticity (Kandel, 2012),
highlighting that the structural plasticity of regeneration and
synaptic plasticity of memory and learning utilize some of the
same transcriptional substrates.
Is cAMP Enough?
While cAMP-mediated gene transcription is an important
contributor to the injury-induced RAG response, the
upregulation of cAMP alone may not harness the robustness of
the conditioning lesion. In studies that have directly compared
axon growth following the conditioning lesion with other
stimuli that increase cAMP to the same extent, conditioning
lesions shows superior efficacy for axonal regeneration (Udina
et al., 2008; Blesch et al., 2012). Indeed, lesion of the peripheral
axon recruits more injury-induced gene transcription than
increasing cAMP alone by the pharmacological inhibition of
its degrading enzyme, PDE4 (Blesch et al., 2012). In light of
the at least 40 transcription factors predicted to contribute
to injury-induced regeneration-associated transcription, these
observations suggest that cAMP-mediated transcription is a
contributor to the overall response, and may control specific
aspects of axon regeneration (Michaelevski et al., 2010).
Accordingly, it is possible that in the absence of axonal injury,
the amount of cAMP accumulated by inhibiting its degradation
or by electrical stimulation is insufficient to recruit the gene
transcription necessary for axonal growth comparable to
the conditioning lesion. A recent study published by the
Filbin group showed that overexpression of soluble AC in
RGCs increased regeneration of crushed optic nerve axons.
Though cAMP levels were not measured in this study, the
data suggest that ongoing cAMP production, which is likely
to be supra physiological, may increase its regeneration-
promoting actions. Further, soluble AC is found in both the
cell body and axon, indicating that the cAMP produced may
simultaneously stimulate both compartments (Martinez et al.,
2014).
RAG expression occurs on the backdrop of the activated
injury-induced signaling cascades that may also have
non-transcriptional effectors. As such, the expression (or
overexpression) of RAGs on their own may not be optimal
for promoting regeneration. For instance, accumulating data
suggests that peripheral injury triggers concerted responses
that prime the neuron to mount an effective transcriptional
response. In this case, the calcium transient triggered by
axotomy stimulates the epigenetic modifications necessary to
facilitate transcription activated by retrograde signals (Cho et al.,
2013). In addition to cAMP-PKA, other signaling molecules can
act in transcription-independent manners. For instance, though
JNK-mediated phosphorylation of c-Jun is necessary for its
transcriptional activity, JNK isoforms also regulate axon growth
through controlling cytoskeletal organization (Barnat et al.,
2010; Ruff et al., 2012). Similarly, local translation initiation of
β-actin, which is required for robust sensory axon regeneration,
requires the Src-mediated phosphorylation of the RNA binding
protein ZBP1 (Huttelmaier et al., 2005; Donnelly et al., 2011).
Together, these effects likely cooperate with RAG transcription
to drive axon regeneration. This makes a case for combining
RAG transcription with the activation of second messengers like
cAMP or Ca2+, in order to more closely recapitulate the injury
conditioning response and drive regeneration.
Previous studies have suggested that cAMP can play a
facilitative role in mediating CNS axon regeneration. In the optic
nerve crush model, RGC axonal regeneration is stimulated by
the release of oncomodulin by macrophages that are recruited
by lens injury. cAMP is required for oncomodulin’s actions on
axon growth, likely through facilitation of receptor binding (Yin
et al., 2006). Given the importance of injury-inducedmacrophage
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recruitment to the DRG for injury conditioning, these factors
may cooperate with cAMP to drive RAG transcription (Kwon
et al., 2013; Niemi et al., 2013). Further, these manipulations
seem to function in parallel to other targets for regeneration,
as combining zymozan, which attracts macrophages that release
oncomodulin, with cAMP and PTEN deletion synergize to allow
some RGC axons to regenerate into the brain and partially
restores some visual function (de Lima et al., 2012). Additionally,
cAMP has been used to enhance the actions of neurotrophic
factors including CNTF in the eye, and NT-3 and BDNF in
the spinal cord to promote axon regeneration in systems where
cAMP alone is insufficient (Cui et al., 2003; Lu et al., 2004,
2012).
Are “Nested” Transcription Factor
Networks the Key?
Though cAMP is sufficient to promote regeneration in some
instances, we wanted to better understand the transcriptional
determinants of cAMP’s actions. Our initial focus was CREB,
as it is a well characterized transcriptional mediator of cAMP
(Lonze and Ginty, 2002). Using a constitutive-active version of
CREB (VP16CREB; CREB-CA) we found that either driving
CREB activity in DRG neurons or application of db-cAMP
alone increased axon growth on inhibitory and permissive
substrates to a similar degree. Surprisingly, axon growth was
significantly increased when CREB-CA-expressing neuron were
treated with db-cAMP, which was paralleled by an increase
in transcription of candidate RAGs. This suggested that levels
of RAG transcription stimulated by CREB or cAMP alone
were insufficient for the maximum observed axon growth in
our paradigm. Interestingly, blocking CREB by expressing a
dominant-negative variant (ACREB; CREB-DN) did not change
cAMP-induced axon growth, indicating that CREB and cAMP
can act synergistically, but also stimulate parallel pathways. This
put forth the notion that CREB may serve as an important
hub for regeneration (Table 1), but that physiological activation
of CREB after injury (likely through cAMP) is insufficient to
recruit the network needed to promote robust regeneration
(Ma et al., 2014). This is supported by work in C. elegans,
whose neurons exhibit robust regenerative capacity. In these
neurons, cAMP upregulation elicited by axotomy-induced Ca2+
influx results in the increase of several basic leucine zipper
domain transcription factors (Ghosh-Roy et al., 2010). Null
mutation in the C. elegans homolog of CREB, crh-1, did
not affect regrowth; however, it did decrease formation of
ventral branches. Mutations of jun-1, however, did result in
reduced regeneration. Taken together, these results suggest
that CREB may not be the primary driver of cAMP-induced
regeneration and that additional transcription factors may be
recruited.
As CREB activity was unnecessary for cAMP’s actions, we
sought the necessary transcription factor(s) downstream of
CREB and cAMP that mediated axon growth. Using arginase 1
(Arg1) as a model RAG, we identified an AP1 site in the proximal
promoter region. Blocking AP1 activity with a dominant-
negative Fos protein (which inhibits AP1 binding to DNA)
blocked both CREB-CA and cAMP-mediated axon growth;
which was mirrored by Arg1 expression levels. Importantly, a
constitutive-active Fos showed only modest increases in axon
growth, suggesting that the AP1-controlled genes cooperate
with other CREB targets to stimulate regeneration (Ma et al.,
2014).
The strong induction of RAG transcription by cAMP +
CREB-CA may induce supra physiological expression of injury-
induced RAGs. Additionally, this artificial activation of CREB
may recruit genes that are not physiologically induced by
peripheral axon injury. For instance, CREB-CA induces high
and persistent levels of c-Fos expression, which is not observed
after peripheral axon injury (Herdegen et al., 1992; Haas
et al., 1993). As AP1 heterodimers containing c-Fos and c-
Jun have higher transcriptional activity than homodimers of c-
Jun, this could further drive the transcription of AP1-dependent
RAGs (Angel and Karin, 1991); however, driving AP1 activity
+ cAMP alone did not recapitulate the effects of CREB-
CA + cAMP, reinforcing the notion that the successful axon
regeneration requires a concerted and broad transcriptional
response. Indeed, the strong activation of CREB recruited other
previously identified hub proteins, such as ATF3, suggesting
that these responses may contain functional ‘‘modules’’ that
mediate specific aspects of axon growth (Ma et al., 2014);
however, the breadth of the overall injury response may indicate
redundancy at higher organizational nodes of the network.
This CREB-activated, AP1-dependent gene module may provide
significant insight to the programs necessary and sufficient to
drive axon growth; its analysis by RNAseq is ongoing. As with
other genome-wide techniques, many genes will be identified,
though only a few will be true RAGs. Understanding the
differences between these two populations may be critical for
identifying the ‘‘optimal’’ approach for driving regeneration.
It is highly probable that other nested transcription factor
networks exist; the evaluation of these should occur in a context
where changes in gene transcription can be correlated to axon
growth/regeneration in order to fully elucidate their contribution
to the phenotype.
Where Do We Go From Here?
With each study of regeneration-associated transcription, we
come closer to elucidating the critical programs required
for axon regeneration. It is evident that the entire RAG
response is difficult to recapitulate in CNS neurons due to
its breadth. As such, therapeutic strategies must target more
manageable critical hubs of RAG transcription or engage
pathways far enough upstream to recruit the genes necessary
to drive axon growth. Future strategies should combine RAG
expression with non-injury induced means of increasing axon
growth. This could pair genetic activation of potential upstream
hubs (i.e., CREB) with the pharmacological upregulation of
relevant signaling pathways (i.e., cAMP) to activate regeneration-
associated transcription (Figure 1). Additionally, combinatorial
strategies that increase metabolic state, recapture developmental
axon growth potential, and favorably modify epigenetic state
of RAGs could function in synergy with RAG expression to
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further promote axon growth following injury. With the proper
experimental design and the explosion of ‘‘big-data’’ analysis
of transcriptomics data, we may now be poised identify the
‘‘regeneration-associated hubs’’ to target, and make good on
the promise of Filbin’s seminal observations on cAMP. We
may find that it isn’t necessary to completely recapitulate
the peripheral-injury response in order to effect significant
regeneration.
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